BENDHEIM JACK (President and CEO) sold 22.0% of their position (21.12K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $1.14M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
−1.65K
Price / share
$55.10
Trade value
$91.02K
% of position
Class A Common Stock
Shares
−4.59K
Price / share
$56.06
Trade value
$257.37K
% of position
Class A Common Stock
Shares
−797.00
Price / share
$56.69
Trade value
$45.18K
% of position
Class A Common Stock
Shares
−4K
Price / share
$52.70
Trade value
$210.91K
% of position
Class A Common Stock
Shares
−3.04K
Price / share
$53.21
Trade value
$161.65K
% of position
Class A Common Stock
Shares
−5.80K
Price / share
$52.65
Trade value
$305.62K
% of position
Class A Common Stock
Shares
−1.24K
Price / share
$53.32
Trade value
$65.85K
% of position
Net shares
−21.12K
Net value
-$1.14M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 4/28/2026 | S · Sale | −1.65K | $55.10 | $91.02K | 1.7% | 95.88K | 94.23K |
| Class A Common Stock Indirect | 4/28/2026 | S · Sale | −4.59K | $56.06 | $257.37K | 4.9% | 94.23K | 89.64K |
| Class A Common Stock Indirect | 4/28/2026 | S · Sale | −797.00 | $56.69 | $45.18K | 0.9% | 89.64K | 88.84K |
| Class A Common Stock Indirect | 4/29/2026 | S · Sale | −4K | $52.70 | $210.91K | 4.5% | 88.84K | 84.84K |
| Class A Common Stock Indirect | 4/29/2026 | S · Sale | −3.04K | $53.21 | $161.65K | 3.6% | 84.84K | 81.80K |
| Class A Common Stock Indirect | 4/30/2026 | S · Sale | −5.80K | $52.65 | $305.62K | 7.1% | 81.80K | 76K |
| Class A Common Stock Indirect | 4/30/2026 | S · Sale | −1.24K | $53.32 | $65.85K | 1.6% | 76K | 74.76K |
| Total | −21.12K | -$1.14M | ||||||
Class A Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |